Multiple Sclerosis (MS)

Multiple Sclerosis (MS) involves communication problems between the brain and the rest of the body due to immune attacks on axons and myelin in the central nervous system. Below are COVID news and research updates that specifically relate to MS.

COVID-19 Vaccination Effects in Those with Multiple Sclerosis

A study published in Neurology Neuroimmunology & Neuroinflammation examined the safety of COVID-19 vaccines in people with multiple sclerosis (MS). The COVER-MS study funded by the National MS Society used an online self-reporting database called iConquerMS to gather information from 719 adults with MS and record information on vaccine side effects. In addition, they were also able to compare the effects of vaccines from different manufacturers and various MS therapies. 

Read More »

Safety of COVID-19 Vaccination in Those with MS, NMOSD, and MOGAD

A recent paper outlined the findings of a new study on the safety and efficacy of COVID-19 vaccines in patients with Multiple Sclerosis (MS), Neuromyelitis Optica spectrum disorder (NMOSD), and Myelin Oligodendrocyte Glycoprotein antibody disease (MOGAD). Researchers in South Korea examined the medical records of 56 patients (19 with MS, 22 with NMOSD, and 15 with MOGAD) to determine the effects of vaccination on this population. 

Read More »

Caring for Autoimmunity & Long COVID with a Personalized Approach

The company Mymee recently published a study on their personalized digital care program for patients living with autoimmune diseases as well as long Covid. Researchers found that over 85% of patients with moderate to severe symptoms saw improvements with their anxiety, depression, fatigue, pain interference, sleep disturbance, and pain intensity while increasing cognitive and physical function.

Read More »